Share ownership Novogene Co., Ltd.

Novogene Co Ltd is a China-based company primarily engaged in gene sequencing. The Company primarily relies on high-throughput sequencing and bioinformatics analysis technologies to establish a gene sequencing platform, combining multi-omics research techniques to provide multi-level scientific research and technical services and solutions for basic life science research, medical and clinical application research. The Company's services mainly include basic life science research services, medical research and technical services, and library preparation and sequencing platform services. The Company's main products include Class III medical devices: human EGFR, KRAS, BRAF, PIK3CA, ALK, and ROS1 gene mutation detection kits (semiconductor sequencing method). The Company operates in both domestic and international markets.